Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
TREM2 and Alzheimer disease are reported together in 8 articles.
Gene
TREM2
- HGNC
- HGNC:17761
10articles
10mentions
1variants with confirmed gene link
Most co-reported phenotypes (articles)
Reported variants (articles · ClinVar status)
Phenotype
Alzheimer disease
455articles
455mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
8 records shown · first 60Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities.
PMID 42362005 | DOI 10.1016/j.mcn.2026.104108 · Molecular and cellular neurosciences · 2026 · 7 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | TREM2 | “So, approaches that potentiate the protective effects of APOE, like APOE mimetics, ABCA1 agonists, targeting APOE receptors like LDLR, LRP1, APOER2, and TREM2, might offer significant therapeutic benefits in Alzheimer's disease.” | 0.98 | hgnc_dict_v1 |
| phenotype | Alzheimer disease | “Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | APOE | “Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities.” | 0.98 | hgnc_dict_v1 |
| gene | LDLR | “One of the key functions of APOE is to bind and deliver newly synthesized cholesterol and lipids to neurons through receptor-mediated endocytosis (LDLR, LRP1, VLDLR, APOER2).” | 0.98 | hgnc_dict_v1 |
TREM2 in neurodegeneration and diseases.
PMID 41792456 | PMCID PMC13268972 | DOI 10.1038/s41380-026-03505-7 · Molecular psychiatry · 2026 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | TREM2 | “TREM2 in neurodegeneration and diseases.” | 0.98 | hgnc_dict_v1 |
| phenotype | Alzheimer disease | “TREM2-initiated signaling plays a crucial role in regulating neuroinflammation and neurodegeneration, particularly in the context of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), through the activation of downstream signaling pathways and transcriptional regulation of relevant genes.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | Parkinson disease | “TREM2-initiated signaling plays a crucial role in regulating neuroinflammation and neurodegeneration, particularly in the context of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), through the activation of downstream signaling pathways and transcriptional regulation of relevant genes.” | 0.93 | phenotype_alias_lexicon_v2 |
GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression.
PMID 40120784 | DOI 10.1016/j.mcn.2025.104005 · Molecular and cellular neurosciences · 2025 · 2 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | TREM2 | “Critical analysis is presented for therapeutic strategies targeting GSK-3β using natural compounds (e.g., curcumin, geniposide) and emerging approaches such as TREM2 modulation and miRNA therapies.” | 0.98 | hgnc_dict_v1 |
| phenotype | Alzheimer disease | “GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression.” | 0.93 | phenotype_alias_lexicon_v2 |
Therapeutic approaches to microglial dysfunction in Alzheimer's disease: Enhancing phagocytosis and metabolic regulation.
PMID 39342887 | DOI 10.1016/j.prp.2024.155614 · Pathology, research and practice · 2024 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | TREM2 | “Genetic polymorphisms in TREM2, APOE, and CD33 highlight the significant impact of microglial dysfunction in AD.” | 0.98 | hgnc_dict_v1 |
| phenotype | Alzheimer disease | “Therapeutic approaches to microglial dysfunction in Alzheimer's disease: Enhancing phagocytosis and metabolic regulation.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | APOE | “Genetic polymorphisms in TREM2, APOE, and CD33 highlight the significant impact of microglial dysfunction in AD.” | 0.98 | hgnc_dict_v1 |
| gene | CD33 | “Genetic polymorphisms in TREM2, APOE, and CD33 highlight the significant impact of microglial dysfunction in AD.” | 0.98 | hgnc_dict_v1 |
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy.
PMID 31594217 | DOI 10.3233/JAD-181259 · Journal of Alzheimer's disease : JAD · 2019 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | TREM2 | “NLRP3 and TREM2 expression was analyzed by RT-PCR; phagocytosis, as well as ASC-Speck formation, was analyzed by Amnis FlowSight Imaging; NLRP3-produced cytokines were quantified by ELISA and, finally, autophagy was analyzed by measuring p-ERK1/2, p-AKT, beclin, p70-S6Kinase, and Lamp by ELISA and western blot.” | 0.98 | hgnc_dict_v1 |
| phenotype | Alzheimer disease | “BACKGROUND: Alzheimer's disease (AD) is associated with the accumulation of amyloid-β (Aβ) within senile plaques in the brain and neuroinflammation, possibly driven by the activation of the NLRP3 inflammasome.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | NLRP3 | “Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy.” | 0.98 | hgnc_dict_v1 |
The Role of TREM2 in Alzheimer's Disease and Other Neurological Disorders.
PMID 25664220 | PMCID PMC4317331 | DOI 10.4172/2161-0460.1000160 · Journal of Alzheimer's disease & Parkinsonism · 2014 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | TREM2 | “The Role of TREM2 in Alzheimer's Disease and Other Neurological Disorders.” | 0.98 | hgnc_dict_v1 |
| phenotype | Alzheimer disease | “The Role of TREM2 in Alzheimer's Disease and Other Neurological Disorders.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | hypertension | “Other environmental risk factors include diabetes mellitus, level of physical activity, educational status, hypertension and head injury.” | 0.98 | phenotype_alias_lexicon_v2 |
| phenotype | diabetes mellitus | “Other environmental risk factors include diabetes mellitus, level of physical activity, educational status, hypertension and head injury.” | 0.98 | phenotype_alias_lexicon_v2 |
Evidence of trem2 variant associated with triple risk of Alzheimer's disease.
PMID 24663666 | PMCID PMC3963925 | DOI 10.1371/journal.pone.0092648 · PloS one · 2014 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | TREM2 | “Our results showed the alteration caused due to the variant in TREM2 protein has significant effect on the ligand binding affinity as well as structural configuration.” | 0.98 | hgnc_dict_v1 |
| phenotype | Alzheimer disease | “Evidence of trem2 variant associated with triple risk of Alzheimer's disease.” | 0.93 | phenotype_alias_lexicon_v2 |
| variant | rs75932628 | “The rare variant discovered is a missense mutation in the loop region of exon 2 of Trem2 (rs75932628-T, Arg47His).” | 0.90 | hgvs_regex_v1 |
The innate immune system in Alzheimer's disease.
PMID 24223593 | PMCID PMC3809371 | DOI 10.1155/2013/576383 · International journal of cell biology · 2013 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | TREM2 | “Recently, it has been reported by two groups independently that a rare functional variant (R47H) of TREM2 is associated with the late-onset risk of AD.” | 0.98 | hgnc_dict_v1 |
| phenotype | Alzheimer disease | “The innate immune system in Alzheimer's disease.” | 0.93 | phenotype_alias_lexicon_v2 |
| variant | R47H | “Recently, it has been reported by two groups independently that a rare functional variant (R47H) of TREM2 is associated with the late-onset risk of AD.” | 0.82 | literature_variant_regex_v2 |